XML 40 R29.htm IDEA: XBRL DOCUMENT
v3.23.3

Stockholders' Equity (Tables) | 9 Months Ended
--- | ---
Sep. 30, 2023
Equity [Abstract] |
Schedule of Cash Dividends Declared | The following table details our cash dividends declared and paid in 2023 through the date hereof:
|  |  |  |  |  |  |  | (Dollars in thousands)
Declaration Date |  | Record Date |  | Payment Date |  | Per Share Amount |  | Total Declared(1)
February 22, 2023 |  | March 16, 2023 |  | March 30, 2023 |  | $ | 0.3125 |  |  | $ | 6,549 |
May 3, 2023 |  | May 25, 2023 |  | June 23, 2023 |  | 0.3125 |  |  | 6,538 |
July 26, 2023 |  | August 17, 2023 |  | September 8, 2023 |  | 0.3125 |  |  | 6,523 |
Total |  |  |  |  |  | $ | 0.9375 |  |  | $ | 19,610 |
(1) The total declared reflects the cash dividends declared in relation to common stock, deferred stock units ("DSUs") and unvested RSUs.
Schedule of Basic and Diluted Net Loss Per Common Shares | The components of basic and diluted net income (loss) per common share were as follows for the periods stated:
| For the Three Months Ended September 30, |  | For the Nine Months Ended September 30,
(in thousands, except for share and per share amounts) | 2023 |  | 2022 |  | 2023 |  | 2022
Numerator: |  |  |  |  |  |  |
Net income (loss) | $ | 4,451 |  |  | $ | 2,920 |  |  | $ | 12,301 |  |  | $ | (2,370) |
Denominator: |  |  |  |  |  |  |
Basic weighted average common shares outstanding | 19,970,936 |  |  | 19,693,659 |  |  | 19,942,325 |  |  | 19,661,849 |
Diluted weighted average common shares outstanding | 20,304,092 |  |  | 19,901,267 |  |  | 20,308,973 |  |  | 19,661,849 |
Basic net income (loss) per common share | $ | 0.22 |  |  | $ | 0.15 |  |  | $ | 0.62 |  |  | $ | (0.12) |
Diluted net income (loss) per common share | $ | 0.22 |  |  | $ | 0.15 |  |  | $ | 0.61 |  |  | $ | (0.12) |
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share | For the three and nine months ended September 30, 2023, and 2022 the following securities were excluded from the calculation of diluted shares outstanding as the effect would have been anti-dilutive:
| For the Three Months Ended September 30, |  | For the Nine Months Ended September 30,
| 2023 |  | 2022 |  | 2023 |  | 2022
Restricted stock units | — |  |  | — |  |  | — |  |  | 290,800 |
Schedule of Activities Under Equity Plan | The following table summarizes the activities under the Equity Plans from January 1, 2023, through September 30, 2023:
| Activity
Total equity securities available at January 1, 2023 | 683,052 |
Additional shares available for issuance under the amended and restated 2020 Equity Plan | 1,000,000 |
RSU, DSU, and restricted stock awarded to eligible employees, net of forfeitures | (398,588) |
Total equity securities available at September 30, 2023 | 1,284,464 |
The following table summarizes the activities under the ESPP from January 1, 2023, through September 30, 2023:
| Activity
Total ESPP equity securities available at January 1, 2023 | 133,184 |
ESPP common stock purchased by eligible employees | (12,558) |
Total ESPP securities available at September 30, 2023 | 120,626 |
Summary of Outstanding RSUs | The following table details activities with respect to outstanding RSUs, DSUs, and restricted stock under the Equity Plans for the nine months ended September 30, 2023:
| Shares |  | Weighted Average Grant Date Fair Value
Unvested at January 1, 2023 | 1,015,749 |  |  | $ | 10.25 |
Granted | 462,512 |  |  | 8.35 |
Vested | (377,686) |  |  | 11.18 |
Forfeited | (63,924) |  |  | 10.28 |
Unvested at September 30, 2023 | 1,036,651 |  |  | $ | 9.06 |
Schedule of Stock Based Compensation Expense | The following table reflects the items for stock-based compensation expense in the Condensed Consolidated Statements of Operations for the periods stated:
| For the Three Months Ended September 30, |  | For the Nine Months Ended September 30,
(Dollars in thousands) | 2023 |  | 2022 |  | 2023 |  | 2022
Performance-based RSUs | $ | 332 |  |  | $ | 362 |  |  | $ | 1,087 |  |  | $ | 1,205 |
Time-based RSUs, DSUs and restricted stock | 536 |  |  | 515 |  |  | 1,613 |  |  | 1,748 |
ESPP | 16 |  |  | — |  |  | 43 |  |  | — |
Total stock-based compensation | $ | 884 |  |  | $ | 877 |  |  | $ | 2,743 |  |  | $ | 2,953 |

X
- Definition Activities under equity plan from inception. + References No definition available. + Details
Name: | spok_ActivitiesUnderEquityPlanFromInceptionTableTextBlock
Namespace Prefix: | spok_
Data Type: | dtr-types1:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of information related to dividends declared, including paid and unpaid dividends. + References No definition available. + Details
Name: | us-gaap_DividendsDeclaredTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_EquityAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1 + Details
Name: | us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1 + Details
Name: | us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (h)(1) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the number and weighted-average grant date fair value for restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock units that were granted, vested, or forfeited during the year. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (c)(1) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration